Challenges and emerging strategies for genome-wide evaluation of loss of imprinting in cancer - Takeaways - MDSpire

Challenges and emerging strategies for genome-wide evaluation of loss of imprinting in cancer

  • By

  • Muhammad Talal Amin

  • Louis Coussement

  • Tim De Meyer

  • June 9, 2026

  • 0 min

Share

  • 1

    Genomic imprinting results in monoallelic gene expression based on parental origin, contrasting with typical biallelic expression.

  • 2

    Imprinting is regulated by epigenetic mechanisms, particularly DNA methylation, and is crucial for early developmental growth.

  • 3

    Dysregulated imprinting patterns are associated with congenital syndromes and various cancers, potentially contributing to tumor growth.

  • 4

    Technical challenges in assessing imprinting in cancer include tumor impurity and the need for heterozygosity to distinguish alleles.

  • 5

    Innovative methodologies, including single-cell approaches, may enhance the characterization of imprinting dysregulation in cancer research.

Original Source(s)

Challenges and emerging strategies for genome-wide evaluation of loss of imprinting in cancer

  • by Muhammad Talal Amin, Louis Coussement, Tim De Meyer

  • June 9, 2026

Related Content

TIFA: a signaling hub linking inflammation, innate immunity, and human disease

The gastrin-releasing peptide receptor in oncology: a comprehensive review of recent advances in targeted radionuclide theranostics

The value of robot-assisted gastrectomy in the treatment of gastric cancer: a systematic review and meta-analysis